Literature DB >> 18284193

Conformer distribution in (cis-1,4-DACH)bis(guanosine-5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin.

Rosa Ranaldo1, Nicola Margiotta, Francesco P Intini, Concetta Pacifico, Giovanni Natile.   

Abstract

In [PtCl2(cis-1,4-DACH)] (DACH = diaminocyclohexane), the N-Pt-N bite angle (> or =97 degrees , as determined by X-ray diffraction analysis) is much larger than those found in other Pt complexes with bidentate diamines or in cisplatin (approximately 91 degrees ). Hence, the possibility exists that in (cis-1,4-DACH)PtG 2 adducts, rotation of the G's around the Pt-N7 bonds is slowed enough to allow observation of different conformers. In accord with this prevision, decreasing the temperature to 238 K enabled us to observe different conformers of (cis-1,4-DACH)Pt(5'-GMP) 2 (GMP = guanosine monophosphate). This observation is the first case in which such conformers for a platinum derivative with primary diamines and untethered guanines have been resolved and represents the closest model to clinically effective cisplatin obtained to date. We also found that the presence of the 1,4-DACH ligand increased the intensity of the circular dichroism signal stemming from the dominance of an HT conformer (DeltaHT in the adduct with 3'-GMPs and LambdaHT in the adduct with 5'-GMPs).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284193     DOI: 10.1021/ic702202x

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Computational evidence for structural consequences of kiteplatin damage on DNA.

Authors:  Shaun T Mutter; Nicola Margiotta; Paride Papadia; James A Platts
Journal:  J Biol Inorg Chem       Date:  2014-11-07       Impact factor: 3.358

2.  Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model.

Authors:  Paride Papadia; Fabrizio Barozzi; James D Hoeschele; Gabriella Piro; Nicola Margiotta; Gian-Pietro Di Sansebastiano
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

3.  A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring.

Authors:  Paride Papadia; Valentina Gandin; Alessandra Barbanente; Alessandro G Ruello; Cristina Marzano; Katia Micoli; James D Hoeschele; Giovanni Natile; Nicola Margiotta
Journal:  RSC Adv       Date:  2019-10-11       Impact factor: 3.361

4.  Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin.

Authors:  Alessandra Barbanente; Angela Galliani; Rosa Maria Iacobazzi; Alessia Lasorsa; Maria Incoronata Nardella; Antonio Pennetta; Nicola Margiotta; Fabio Arnesano
Journal:  ChemMedChem       Date:  2021-11-15       Impact factor: 3.540

5.  Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.

Authors:  Salvatore Savino; Cristina Marzano; Valentina Gandin; James D Hoeschele; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2018-07-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.